Dr. Anees Afroze, M.D

NPI: 1043352057
Total Payments
$7,337
2024 Payments
$3,869
Companies
37
Transactions
280
Medicare Patients
1,499
Medicare Billing
$271,701

Payment Breakdown by Category

Food & Beverage$3,948 (53.8%)
Travel$1,869 (25.5%)
Education$1,520 (20.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,948 271 53.8%
Travel and Lodging $1,869 7 25.5%
Education $1,520 2 20.7%

Top Paying Companies

Company Total Records Latest Year
INTUITIVE SURGICAL, INC. $3,386 9 $0 (2024)
GlaxoSmithKline, LLC. $859.76 75 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $545.23 42 $0 (2024)
AstraZeneca Pharmaceuticals LP $438.71 20 $0 (2024)
Genentech USA, Inc. $282.22 21 $0 (2024)
Sunovion Pharmaceuticals Inc. $197.38 16 $0 (2018)
Actelion Pharmaceuticals US, Inc. $154.82 9 $0 (2024)
Chiesi USA, Inc. $145.36 3 $0 (2021)
Novartis Pharmaceuticals Corporation $133.98 9 $0 (2019)
Grifols USA, LLC $106.38 8 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,869 36 INTUITIVE SURGICAL, INC. ($3,386)
2023 $211.62 12 Genentech USA, Inc. ($31.81)
2022 $136.83 7 ABBVIE INC. ($37.19)
2021 $116.02 1 Chiesi USA, Inc. ($116.02)
2020 $123.12 10 GlaxoSmithKline, LLC. ($46.19)
2019 $1,149 79 GlaxoSmithKline, LLC. ($283.37)
2018 $1,062 81 GlaxoSmithKline, LLC. ($321.88)
2017 $669.23 54 GlaxoSmithKline, LLC. ($195.11)

All Payment Transactions

280 individual payment records from CMS Open Payments — Page 1 of 12

Date Company Product Nature Form Amount Type
12/17/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $13.69 General
12/11/2024 CSL Behring Kcentra (Biological) Food and Beverage In-kind items and services $32.20 General
Category: Trauma (Emergency, Injury, Surgery)
11/26/2024 Grifols USA, LLC Xembify (Biological) Food and Beverage In-kind items and services $13.16 General
Category: Immunology and Neurology
11/20/2024 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $13.22 General
Category: Respiratory
10/31/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Food and Beverage In-kind items and services $18.17 General
Category: RESPIRATORY
10/22/2024 JAZZ PHARMACEUTICALS INC. XYWAV (Drug) Food and Beverage In-kind items and services $16.29 General
Category: NEUROLOGY
10/17/2024 Amgen Inc. TEZSPIRE (Biological) Food and Beverage In-kind items and services $14.91 General
Category: Inflammation
10/09/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $18.91 General
Category: IMMUNOLOGY
10/07/2024 Grifols USA, LLC Prolastin-C Liquid (Biological) Food and Beverage In-kind items and services $14.61 General
Category: Pulmonology
09/17/2024 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $19.00 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
07/10/2024 IDORSIA PHARMACEUTICALS US INC QUVIVIQ (Drug) Food and Beverage In-kind items and services $19.71 General
Category: Insomnia
06/20/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $13.23 General
Category: Respiratory
06/19/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $22.26 General
Category: INFLAMMATION AND IMMUNOLOGY
06/18/2024 JAZZ PHARMACEUTICALS INC. XYWAV (Drug) Food and Beverage In-kind items and services $19.55 General
Category: NEUROLOGY
05/23/2024 ABBVIE INC. AVYCAZ (Drug) Food and Beverage In-kind items and services $20.42 General
Category: ANTI-INFECTIVE
05/16/2024 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $14.02 General
Category: Respiratory
05/14/2024 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $19.66 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
05/01/2024 Mylan Specialty L.P. YUPELRI (Drug) Food and Beverage In-kind items and services $16.22 General
Category: Anticholinergics, Inhaled
04/30/2024 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $16.92 General
Category: Respiratory
04/02/2024 CSL Behring Kcentra (Biological) Education In-kind items and services $20.00 General
Category: Trauma (Emergency, Injury, Surgery)
02/22/2024 Genentech USA, Inc. Xolair (Biological) Food and Beverage In-kind items and services $20.74 General
Category: Immunology
02/16/2024 INTUITIVE SURGICAL, INC. Da Vinci Surgical System (Device) Education In-kind items and services $1,500.00 General
Category: SURGERY
02/14/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $14.14 General
Category: Respiratory
02/05/2024 INTUITIVE SURGICAL, INC. Da Vinci Surgical System (Device) Travel and Lodging In-kind items and services $121.00 General
Category: SURGERY
02/03/2024 INTUITIVE SURGICAL, INC. Da Vinci Surgical System (Device) Travel and Lodging In-kind items and services $231.86 General
Category: SURGERY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 264 384 $190,291 $41,297
2022 9 380 599 $313,210 $65,943
2021 11 387 696 $329,906 $82,452
2020 10 468 753 $320,237 $82,008
Total Patients
1,499
Total Services
2,432
Medicare Billing
$271,701
Procedure Codes
39

All Medicare Procedures & Services

39 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99291 Critical care, first 30-74 minutes Facility 2023 78 150 $140,040 $23,654 16.9%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 54 78 $17,690 $7,089 40.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 62 77 $15,627 $5,095 32.6%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 15 16 $4,646 $1,589 34.2%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 16 16 $5,400 $1,420 26.3%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 17 22 $3,485 $1,329 38.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 22 25 $3,403 $1,120 32.9%
99291 Critical care, first 30-74 minutes Facility 2022 120 266 $248,338 $42,621 17.2%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 80 146 $33,113 $10,737 32.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 37 41 $10,838 $4,351 40.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 24 27 $7,873 $3,468 44.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 21 21 $3,762 $1,549 41.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 16 16 $3,456 $1,438 41.6%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 16 16 $2,534 $859.96 33.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 11 11 $1,273 $552.53 43.4%
94727 Test to determine lung volumes using gas dilution or washout Office 2022 20 20 $792.00 $156.74 19.8%
94729 Test to examine how well the lungs exchange gases Office 2022 20 20 $528.00 $116.11 22.0%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Office 2022 15 15 $702.00 $94.68 13.5%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2021 133 334 $258,988 $56,262 21.7%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 96 187 $44,495 $14,693 33.0%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 33 41 $9,963 $5,522 55.4%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 18 19 $3,420 $1,758 51.4%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 17 17 $4,324 $1,758 40.7%
99292 Critical care delivery critically ill or injured patient Facility 2021 12 13 $4,238 $1,102 26.0%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 13 17 $2,628 $929.39 35.4%

About Dr. Anees Afroze, M.D

Dr. Anees Afroze, M.D is a Internal Medicine healthcare provider based in Springfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1043352057.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anees Afroze, M.D has received a total of $7,337 in payments from pharmaceutical and medical device companies, with $3,869 received in 2024. These payments were reported across 280 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($3,948).

As a Medicare-enrolled provider, Afroze has provided services to 1,499 Medicare beneficiaries, totaling 2,432 services with total Medicare billing of $271,701. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Pulmonary Disease
  • Location Springfield, MO
  • Active Since 02/13/2007
  • Last Updated 12/27/2018
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1043352057

Products in Payments

  • Da Vinci Surgical System (Device) $3,386
  • TRELEGY ELLIPTA (Drug) $343.14
  • OFEV (Drug) $308.32
  • Xolair (Biological) $225.27
  • NUCALA (Biological) $180.46
  • BREO (Drug) $177.60
  • FASENRA (Drug) $155.78
  • STIOLTO RESPIMAT (Drug) $154.66
  • CLEVIPREX (Drug) $145.36
  • AVYCAZ (Drug) $136.83
  • XOLAIR (Biological) $133.98
  • ANORO (Drug) $127.05
  • BEVESPI AEROSPHERE (Drug) $105.04
  • Arikayce (Drug) $85.49
  • Prolastin-C Liquid (Biological) $80.38
  • Letairis (Drug) $74.25
  • OPSUMIT MACITENTAN (Drug) $69.65
  • LONHALA MAGNAIR (Drug) $68.51
  • FASENRA (Biological) $67.87
  • OPSUMIT (Drug) $67.15

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Springfield